Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ascendis Pharma (ASND)
NASDAQ:ASND
Ascendis Pharma (ASND) Stock Forecast & Price Target
480 Followers
See the Price Targets and Ratings of:
ASND Analyst Ratings
Strong Buy
9 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ASND Stock 12 Month Forecast
Average Price Target
$183.13
▲(35.44% Upside)
| Highest Price Target$260.00 | Average Price Target$183.13 | Lowest Price Target$140.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Morgan Stanley
Reiterated
07/15/24
Wells Fargo
Assigned
07/11/24
TD Cowen
Upgraded
06/25/24
Bank of America Securities
Reiterated
06/11/24
Citi
Reiterated
06/03/24
Stifel Nicolaus
Initiated
05/31/24
Oppenheimer
Reiterated
05/15/24
Leerink Partners
Reiterated
05/14/24
J.P. Morgan
Reiterated
05/14/24
Goldman Sachs
Reiterated
05/14/24
Cantor Fitzgerald
$173
Buy
$173.00
(27.95% Upside)
Reiterated
05/14/24
Analysts Are Bullish on These Healthcare Stocks: Ascendis Pharma (ASND), Sanara MedTech (SMTI)
Evercore ISI
$181→$191
Buy
$191.00
(41.26% Upside)
Reiterated
03/14/24
Ascendis Pharma (ASND) PT Raised to $191 at Evercore ISIEvercore ISI analyst Josh Schimmer raised the price target on Ascendis Pharma (NASDAQ: ASND) to $191.00 (from $181.00) while maintaining a Outperform rating.
Jefferies
$174
Buy
$174.00
(28.69% Upside)
Reiterated
02/19/24
Analysts Offer Insights on Healthcare Companies: Guardant Health (NASDAQ: GH), IQVIA Holdings (NYSE: IQV) and Ascendis Pharma (NASDAQ: ASND)
Berenberg Bank
$166
Buy
$166.00
(22.77% Upside)
Reiterated
09/07/23
Berenberg Bank Reaffirms Their Buy Rating on Ascendis Pharma (ASND)
Best Analysts Covering Ascendis Pharma
Which Analyst Should I Follow If I Want to Buy ASND and Sell After:
1 Month
xxx
Success Rate
18/25 ratings generated profit
Average Return
+3.28%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 72.00% of your transactions generating a profit, with an average return of +3.28% per trade.
3 Months
xxx
Success Rate
16/25 ratings generated profit
Average Return
+7.40%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 64.00% of your transactions generating a profit, with an average return of +7.40% per trade.
1 Year
Success Rate
18/22 ratings generated profit
Average Return
+30.19%
reiterated a buy rating last month
Copying Tazeen Ahmad's trades and holding each position for 1 Year would result in 81.82% of your transactions generating a profit, with an average return of +30.19% per trade.
2 Years
xxx
Success Rate
20/22 ratings generated profit
Average Return
+63.89%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 90.91% of your transactions generating a profit, with an average return of +63.89% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ASND Analyst Recommendation Trends
Rating
Mar 24
Apr 24
May 24
Jun 24
Jul 24
Strong Buy
2
2
3
2
3
Buy
20
13
18
18
16
Hold
3
2
4
6
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
25
17
25
26
28
Each month's total comprises the sum of three months' worth of ratings.
ASND Financial Forecast
ASND Stock Forecast FAQ
What is ASND’s average 12-month price target, according to analysts?
Based on analyst ratings, Ascendis Pharma’s 12-month average price target is $183.13.
What is ASND’s upside potential, based on the analysts’ average price target?
Ascendis Pharma has 35.44% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ASND a Buy, Sell or Hold?
Ascendis Pharma has a consensus rating of Strong Buy which is based on 9 buy ratings, 2 hold ratings and 0 sell ratings.
What is Ascendis Pharma’s price target?
The average price target for Ascendis Pharma is $183.13. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $260.00 ,the lowest forecast is $140.00. The average price target represents 35.44% Increase from the current price of $135.21.
The highest analyst price target is $260.00 ,the lowest forecast is $140.00. The average price target represents 35.44% Increase from the current price of $135.21.
What do analysts say about Ascendis Pharma?
Ascendis Pharma’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of ASND?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.